Circulating microparticles: pathophysiology and clinical implications

Blood Reviews

Volumn 21, Issue 3, 2007, Pages 157-171

  Piccin, Andrea ^a   Murphy, William G ^a   Smith, Owen P ^b  

^a IRISH BLOOD TRANSFUSION SERVICE   (Ireland)

^b OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

EMP; Microparticles; PMP; Review

Indexed keywords

AMINOPHOSPHOLIPID; CALPAIN; CARRIER PROTEIN; GELSOLIN; SCRAMBLASE;

AORTA ANEURYSM; APLASTIC ANEMIA; ARTICLE; BLOOD CELL; CELL DAMAGE; CELL MEMBRANE; CELL SURFACE; CYTOSKELETON; DEEP VEIN THROMBOSIS; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FREEZING; HEMOGLOBINURIA; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; LUNG EMBOLISM; MONOCYTE; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEPSIS; SICKLE CELL ANEMIA; SURFACE PROPERTY; VASCULAR ENDOTHELIUM;

BLOOD CELLS; BLOOD PLATELETS; CARDIOVASCULAR DISEASES; CELL MEMBRANE; ENDOTHELIUM, VASCULAR; HUMANS; MONOCYTES; PARTICLE SIZE;

EID: 34047111681     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.blre.2006.09.001     Document Type: Article

References (104)

1. Chargaff E., and West R. The biological significance of the thromboplastic protein of blood. J Biol Chem 166 (1946) 189-197
2. Wolf P. The nature and significance of platelet products in human plasma. Brit J Haematol 13 3 (1967) 269-288
3. Combes V., Simon A.C., Grau G.E., Arnoux D., Camoin L., Sabatier F., et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 104 1 (1999) 93-102
4. Satta N., Toti F., Feugeas O., Bohbot A., Dachary-Prigent J., Eschwege V., et al. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol 153 7 (1994) 3245-3255
5. Iida K., Whitlow M.B., and Nussenzweig V. Membrane vesiculation protects erythrocytes from destruction by complement. J Immunol 147 (1991) 2638-2642
6. Salzer U., Hinterdorfer P., Hunger U., Borken C., and Prohaska R. Ca++-dependent vesicle release from erythrocytes involves stomatin-specific lipid rafts, synexin (annexin VII), and sorcin. Blood 99 (2002) 2569-2577
7. Wagner G.M., Chiu D.T., Yee M.C., and Lubin B.H. Red cell vesiculation-a common membrane physiologic event. J Lab Clin Med 108 4 (1986) 315-324
8. Greenwalt T.J. The how and why of exocytic vesicles. Transfusion 46 1 (2006) 143-152
9. Allan D., Thomas P., and Limbrick A.R. The isolation and characterization of 60 nm vesicles ('nanovesicles') produced during ionophore A23187-induced budding of human erythrocytes. Biochem J 188 3 (1980) 881-887
10. Bevers E.M., Comfurius P., van Rijn J.L., Hemker H.C., and Zwaal R.F. Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem 122 2 (1982) 429-436
11. Zwaal R.F., and Bevers E.M. Platelet phospholipid asymmetry and its significance in hemostasis. Subcell Biochem 9 (1983) 299-334
12. van Dieijen G., Tans G., Rosing J., and Hemker H.C. The role of phospholipid and factor VIIIa in the activation of bovine factor X. J Biol Chem 256 7 (1981) 3433-3442
13. Rosing J., Speijer H., and Zwaal R.F. Prothrombin activation on phospholipid membranes with positive electrostatic potential. Biochemistry 27 1 (1988) 8-11
14. Schroit A.J., Tanaka Y., Madsen J., and Fidler I.J. The recognition of red blood cells by macrophages: role of phosphatidylserine and possible implications of membrane phospholipid asymmetry. Biol Cell 51 2 (1984) 227-238
15. Fox J.E., Austin C.D., Boyles J.K., and Steffen P.K. Role of the membrane skeleton in preventing the shedding of procoagulant-rich microvesicles from the platelet plasma membrane. J Cell Biol 111 2 (1990) 483-493
16. Diaz C., and Schroit A.J. Role of translocases in the generation of phosphatidylserine asymmetry. J Membr Biol 151 1 (1996) 1-9
17. Connor J., Pak C.H., Zwaal R.F., and Schroit A.J. Bidirectional transbilayer movement of phospholipid analogs in human red blood cells Evidence for an ATP-dependent and protein-mediated process. J Biol Chem 267 27 (1992) 19412-19417
18. McLaughlin P.J., Gooch J.T., Mannherz H.G., and Weeds A.G. Structure of gelsolin segment 1-actin complex and the mechanism of filament severing. Nature 364 6439 (1993) 685-692
19. Beleznay Z., Zachowski A., Devaux P.F., Navazo M.P., and Ott P. ATP-dependent aminophospholipid translocation in erythrocyte vesicles: stoichiometry of transport. Biochemistry 32 12 (1993) 3146-3152
20. Zwaal R.F., Comfurius P., and Bevers E.M. Mechanism and function of changes in membrane-phospholipid asymmetry in platelets and erythrocytes. Biochem Soc Trans 21 2 (1993) 248-253
21. Weiss H.J., Vicic W.J., Lages B.A., and Rogers J. Isolated deficiency of platelet procoagulant activity. Am J Med 67 2 (1979) 206-213
22. Zwaal R.F., Comfurius P., and Bevers E.M. Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids. Biochim Biophys Acta 1636 2-3 (2004) 119-128
23. Dachary-Prigent J., Pasquet J.M., Fressinaud E., Toti F., Freyssinet J.M., and Nurden A.T. Aminophospholipid exposure, microvesiculation and abnormal protein tyrosine phosphorylation in the platelets of a patient with Scott syndrome: a study using physiologic agonists and local anaesthetics. Brit J Haematol 99 4 (1997) 959-967
24. Toti F., Satta N., Fressinaud E., Meyer D., and Freyssinet J.M. Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood 87 4 (1996) 1409-1415
25. Castaman G., Yu-Feng L., Battistin E., and Rodeghiero F. Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generation. Brit J Haematol 96 3 (1997) 458-463
26. Murphy W.G., Moore J.C., and Kelton J.G. Calcium-dependent cysteine protease activity in the sera of patients with thrombotic thrombocytopenic purpura. Blood 70 (1987) 1683-1687
27. Kelton J.G., Warkentin T.E., Hayward C.P., Murphy W.G., and Moore J.C. Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles. Blood 80 9 (1992) 2246-2251
28. Harwig J.H. Platelet structure. In: Michelson A.D. (Ed). Platelet (2002), Academic Press 37-49
29. JY W., Horstman L.L., Jimenez J.J., and Ahn Y.S. Measuring circulating cell-derived microparticles. J Thromb Haemost 2 10 (2004) 1850-1851
30. Macey M., Azam U., McCarthy D., Webb L., Chapman E.S., Okrongly D., et al. Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology system. Clin Chem 48 (2002) 891-899
31. Philippe J., De Logi E., and Baele G. Comparison of five different citrated tubes and their in vitro effects on platelet activation. Clin Chem 50 3 (2004) 656-658
32. Golansky J., Pietrucha T., Baj Z., Greger J., and Watala C. Molecular insights into the anticoagulant-induced spontaneous activation of platelets in whole blood- various anticoagulant are not equal. Thromb Res 83 (1996) 199-216
33. Biro E., Nieuwland R., and Sturk A. Measuring circulating cell-derived microparticles. J Thromb Haemost 2 10 (2004) 1843-1844
34. Shet A.S., Key N.S., and Hebbel R.P. Measuring circulating cell-derived microparticles. J Thromb Haemost 2 10 (2004) 1848-1850
35. Simak J., Holada K., Risitano A.M., Zivny J.H., Young N.S., and Vostal J.G. Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria. Brit J Haematol 125 6 (2004) 804-813
36. Shet A.S., Aras O., Gupta K., Hass M.J., Rausch D.J., Saba N., et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 102 7 (2003) 2678-2683
37. Ahmad S., Amirkhosravi A., Langer F., Desai H., Amaya M., and Francis J.L. Importance of pre-analytical variables in the measurement of platelet-derived microparticles. J Thromb Haemostas 3 Suppl 1 (2005) abstract #02286
38. Thiagarajan P., and Tait J.F. Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles. J Biol Chem 266 36 (1991) 24302-24307
39. Horstman L.L., Jy W., Jimenez J.J., Bidot C., and Ahn Y.S. New horizons in the analysis of circulating cell-derived microparticles. Keio J Med 53 4 (2004) 210-230
40. Niuwland R., and Strurk A. Platelet derived microparticles. In: Michelson A.D. (Ed). Platelet (2002), Academic Press 255-265
41. Nomura S. Measuring circulating cell-derived microparticles. J Thromb Haemost 2 10 (2004) 1847-1848
42. Miyamoto S., Marcinkiewicz C., Edmunds Jr. L.H., and Niewiarowski S. Measurement of platelet microparticles during cardiopulmonary bypass by means of captured ELISA for GpIIb/IIIa. Thromb Haemost 80 2 (1998) 225-230
43. Losy J., Niezgoda A., and Wender M. Increased serum levels of soluble PECAM-1 in multiple sclerosis patients with brain gadolinium-enhancing lesions. J Neuroimmunol 99 2 (1999) 169-172
44. Schwarz M., Katagiri Y., Kotani M., Bassler N., Loeffler C., Bode C., et al. Reversibility versus persistence of GpIIb/IIIa blocker-induced conformational change of GpIIb/IIIa (alphaIIbbeta3, CD41/CD61). J Pharmacol Exp Ther 308 3 (2004) 1002-1011
45. George J.N., Pickett E.B., Saucerman S., McEver R.P., Kunicki T.J., Kieffer N., et al. Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest 78 2 (1986) 340-348
46. Tschoepe D., Spangenberg P., Esser J., Schwippert B., Kehrel B., Roesen P., et al. Flow-cytometric detection of surface membrane alterations and concomitant changes in the cytoskeletal actin status of activated platelets. Cytometry 11 5 (1990) 652-656
47. von Ahsen N., Ehrlich B., Scott C.S., Riggert J., and Oellerich M. Cryoglobulins interfere with platelet counts by optical and impedance methods but not with the CD61 immunoplatelet count. Clin Chem 47 10 (2001) 1858-1860
48. Horstman L.L., and Ahn Y.S. Platelet microparticles: a wide-angle perspective. Crit Rev Oncol Hematol 30 2 (1999) 111-142
49. Mutin M., Dignat-George F., and Sampol J. Immunologic phenotype of cultured endothelial cells: quantitative analysis of cell surface molecules. Tissue Antigens 50 5 (1997) 449-458
50. Horstman L.L., Jy W., Jimenez J.J., and Ahn Y.S. Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 9 (2004) 1118-1135
51. Jimenez J.J., Jy W., Mauro L.M., Soderland C., Horstman L.L., and Ahn Y.S. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 109 4 (2003) 175-180
52. Abid Hussein M.N., Meesters E.W., Osmanovic N., Romijn F.P., Nieuwland R., and Sturk A. Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo. J Thromb Haemost 1 11 (2003) 2434-2443
53. Berckmans R.J., Neiuwland R., Boing A.N., Romijn F.P., Hack C.E., and Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 85 4 (2001) 639-646
54. Sims P.J., Wiedmer T., Esmon C.T., Weiss H.J., and Shattil S.J. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem 264 29 (1989) 17049-17057
55. Hamilton K.K., Hattori R., Esmon C.T., and Sims P.J. Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. J Biol Chem 265 7 (1990) 3809-3814
56. Jy W., Jimenez J.J., Mauro L.M., Horstman L.L., Cheng P., Ahn E.R., et al. Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ristocetin dependent pathway, rendering them resistant to dissociation. Thromb Haemost 3 6 (2005) 1301-1308
57. Celi A., Lorenzet R., Furie B.C., and Furie B. Microparticles and a P-selectin-mediated pathway of blood coagulation. Dis Markers 20 6 (2004) 347-352
58. Del Conde I., Shrimpton C.N., Thiagarajan P., and Lopez J.A. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106 5 (2005) 1604-1611
59. Rauch U., Bonderman D., Bohrmann B., Badimon J.J., Himber J., Riederer M.A., et al. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood 96 1 (2000) 170-175
60. Jy W., Horstman L.L., Arce M., and Ahn Y.S. Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med 119 4 (1992) 334-345
61. Sims P.J., Faioni E.M., Wiedmer T., and Shattil S.J. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 263 34 (1988) 18205-18212
62. Comfurius P., Bevers E.M., Galli M., and Zwaal R.F. Regulation of phospholipid asymmetry and induction of antiphospholipid antibodies. Lupus 4 Suppl 1 (1995) S19-S22
63. Casciola-Rosen L., Rosen A., Petri M., and Schlissel M. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci 93 4 (1996) 1624-1629
64. Bombeli T., Karsan A., Tait J.F., and Harlan J.M. Apoptotic vascular endothelial cells become procoagulant. Blood 89 7 (1997) 2429-2442
65. Francis Jr. R.B., and Hebbel R.P. Hemostasis. In: Embury S.H., Hebbel R.P., Steiberh M.H., and Mohandas N. (Eds). Sickle Cell Disease: Basic principles and Clinical practice (1994), Raven Press, New York 299-310
66. Manodori A.B., Matsui N.M., Chen J.Y., and Embury S.H. Enhanced adherence of sickle erythrocytes to thrombin-treated endothelial cells involves interendothelial cell gap formation. Blood 92 9 (1998) 3445-3454
67. Solovey A., Gui L., Key N.S., and Hebbel R.P. Tissue factor expression by endothelial cells in sickle cell anemia. J Clin Invest 101 9 (1998) 1899-1904
68. Key N.S., Slungaard A., Dandelet L., Nelson S.C., Moertel C., Styles L.A., et al. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood 91 11 (1998) 4216-4223
69. Hebbel R.P., Osarogiagbon R., and Kaul D. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy. Microcirculation 11 2 (2004) 129-151
70. Visentin G.P., Ford S.E., Scott J.P., and Aster R.H. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 93 1 (1994) 81-88
71. McKenzie S.E., and Reilly M.P. Heparin-induced thrombocytopenia and other immune thrombocytopenias: lessons from mouse models. Semin Thromb Hemostas 30 (2004) 559-564
72. Barry O.P., Pratico D., Savani R.C., and FitzGerald G.A. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 102 1 (1998) 136-144
73. Soriano A.O., Jy W., Chirinos J.A., Valdivia M.A., Velasquez H.S., Jimenez J.J., et al. Levels of endothelial and platelet microparticles and their interactions with leukocytes negatively correlate with organ dysfunction and predict mortality in severe sepsis. Crit Care Med 33 11 (2005) 2540-2546
74. Nieuwland R., Berckmans R.J., McGregor S., Boing A.N., Romijn F.P., Westendorp R.G., et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 95 3 (2000) 930-935
75. Furlan M., Robles R., Galbusera M., Remuzzi G., Kyrle P.A., Brenner B., et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339 22 (1998) 1578-1584
76. Jimenez J.J., Jy W., Mauro L.M., Horstman L.L., and Ahn Y.S. Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease. Brit J Haematol 112 1 (2001) 81-90
77. Murphy W.G., Moore J.C., Barr R.D., Pai M.K.R., and Kelton J.G. Relationship between platelet aggregating factor and von Willebrand factor in thrombotic thrombocytopenic purpura. Brit J Haematol 66 (1987) 509-514
78. Fox J.E. Shedding of adhesion receptors from the surface of activated platelets. Blood Coagulation Fibrinolysis 5 2 (1994) 291-304
79. Hugel B., Socie G., Vu T., Toti F., Gluckman E., Freyssinet J.M., et al. Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood 93 10 (1999) 3451-3456
80. Ogata N., Imaizumi M., Nomura S., Shozu A., Arichi M., Matsuoka M., et al. Increased levels of platelet-derived microparticles in patients with diabetic retinopathy. Diabetes Res Clin Pract 68 (2005) 193-201
81. Omoto S., Nomura S., Shouzu A., Hayakawa T., Shimizu H., Miyake Y., et al. Significance of platelet-derived microparticles and activated platelets in diabetic nephropathy. Nephron 81 3 (1999) 271
82. Omoto S., Nomura S., Shouzu A., Nishikawa M., Fukuhara S., and Iwasaka T. Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus. Diabetologia 45 4 (2002) 550-555
83. Diamant M., Nieuwland R., Pablo R.F., Sturk A., Smit J.W., and Radder J.K. Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation 106 19 (2002) 2442-2447
84. Faure V., Dou L., Sabatier F., Cerini C., Sampol J., Berland Y., et al. Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost 4 3 (2006) 566-573
85. Bernal-Mizrachi L., Jy W., Jimenez J.J., Pastor J., Mauro L.M., Horstman L.L., et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 145 6 (2003) 962-970
86. Bernal-Mizrachi L., Jy W., Fierro C., MacDonough R., Velazques H.A., Purow J., et al. Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes. Int J Cardiol 97 3 (2004) 439-446
87. Werner N., Wassmann S., Ahlers P., Kosiol S., and Nickenig G. Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 26 1 (2006) 112-116
88. Simak J., Gelderman M.P., Yu H., Wright V., and Baird A.E. Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome. J Thromb Haemost 4 6 (2006) 1296-1302
89. Faure V., Dou L., Sabatier F., Cerini C., Sampol J., Berland Y., et al. Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost 4 3 (2006) 566-573
90. Tan K.T., Tayebjee M.H., Macfadyen R.J., Lip G.Y., and Blann A.D. Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammation. Platelets 16 6 (2005) 368-371
91. Boulanger C.M., Scoazec A., Ebrahimian T., Henry P., Mathieu E., Tedgui A., et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 104 22 (2001) 2649-2652
92. Lee Y.J., Jy W., Horstman L.L., Janania J., Reyes Y., Kelley R.E., et al. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multi-infarct dementias. Thromb Res 72 4 (1993) 295-304
93. Touat Z., Ollivier V., Dai J., Huisse M.G., Bezeaud A., Sebbag U., et al. Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution. Am J Pathol 168 3 (2006) 1022-1030
94. Falati S., Liu Q., Gross P., Merrill-Skoloff G., Chou J., Vandendries E., et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 197 11 (2003) 1585-1598
95. Heresi G.A., Chirinos J.A., Velasquez H., Zambrano J.P., Soriano A.O., Horstman L.L., et al. Elevated endothelial Microparticles (EMP) and activation markers of platelet and leukocytes in venous thromboembolism (VTE). Blood 102 (2003) 804a
96. Rectenwald J.E., Myers Jr. D.D., Hawley A.E., Longo C., Henke P.K., Guire K.E., et al. D-dimer, P-selectin, and microparticles: novel markers to predict deep venous thrombosis. A pilot study. Thromb Haemost 94 6 (2005) 1312-1317
97. Jy W., Horstman L.L., Wang F., Duncan R.C., and Ahn Y.S. Platelet factor 3 in plasma fractions: its relation to microparticle size and thromboses. Thromb Res 80 6 (1995) 471-482
98. Steppich B., Mattisek C., Sobczyk D., Kastrati A., Schomig A., and Ott I. Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction. Thromb Haemost 93 1 (2005) 35-39
99. Wakefield T.W., and Henke P.K. The role of inflammation in early and late venous thrombosis: Are there clinical implications?. Semin Vasc Surg 18 3 (2005) 118-129
100. van der Zee P.M., Biro E., Ko Y., de Winter R.J., Hack C.E., Sturk A., et al. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin Chem 52 4 (2006) 657-664
101. Tan K.T., Tayebjee M.H., Lynd C., Blann A.D., and Lip G.Y. Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers. Ann Med 37 1 (2005) 61-66
102. George J.N., Pickett E.B., and Heinz R. Platelet membrane microparticles in blood bank fresh frozen plasma and cryoprecipitate. Blood 68 (1986) 307-309
103. Blajchman M.A. Substitutes and alternatives to platelet transfusions in thrombocytopenic patients. J Thromb Haemostas 1 7 (2003) 1637-1641
104. McCullough J., Vesole D.H., Benjamin R.J., Slichter S.J., Pineda A., Snyder E., et al. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. Blood 104 5 (2004) 1534-1541